These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17339258)

  • 1. Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapy.
    Molina-Infante J; Perez-Gallardo B; Gonzalez-Garcia G; Fernandez-Bermejo M; Mateos-Rodriguez JM; Robledo-Andres P
    Gut; 2007 Mar; 56(3):447. PubMed ID: 17339258
    [No Abstract]   [Full Text] [Related]  

  • 2. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
    Coutance G; Saplacan V; Belin A; Repessé Y; Buklas D; Massetti M
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Octreotide long acting release for severe obscure gastrointestinal haemorrhage in elderly patients with serious comorbidities].
    Molina Infante J; Pérez Gallardo B; Hernández Alonso M; Mateos Rodríguez JM; Dueñas Sadornil C; Fernández Bermejo M
    Med Clin (Barc); 2009 Nov; 133(17):667-70. PubMed ID: 19781724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a somatostatin analogue in occult gastrointestinal bleeding: a case report.
    Tamagno G; Mioni R; De Carlo E; Maffei P; Rubello D; Sicolo N
    Dig Liver Dis; 2004 Dec; 36(12):843-6. PubMed ID: 15646433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heart failure, anemia and angiodysplasia: what else can we do?].
    Méndez Balión M; Muñoz Rivas N
    Med Clin (Barc); 2011 Jan; 136(2):85-6. PubMed ID: 20022064
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propranolol.
    Krikis N; Tziomalos K; Perifanis V; Vakalopoulou S; Karagiannis A; Garipidou V; Harsoulis F
    Gut; 2005 Jan; 54(1):171-2. PubMed ID: 15591529
    [No Abstract]   [Full Text] [Related]  

  • 7. [Octreotide in bleeding caused by intestinal angiodysplasia].
    Lourdes Ruiz Rebollo M; Barrio Andrés J; Fernández-Orcajo P; Prada Lobato J; Mena Martín FJ; Velicia Llames R; Caro-Paton A
    Gastroenterol Hepatol; 2008 Dec; 31(10):713-4. PubMed ID: 19174089
    [No Abstract]   [Full Text] [Related]  

  • 8. Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?
    Rennyson SL; Shah KB; Tang DG; Kasirajan V; Pedram S; Cahoon W; Malhotra R
    ASAIO J; 2013; 59(4):450-1. PubMed ID: 23820288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide for palliative treatment of bleeding from unresectable gastric cancer.
    Sanaka M; Yamamoto T; Kawakami T; Kuyama Y
    Hepatogastroenterology; 2005; 52(64):2 p preceding I. PubMed ID: 16001612
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of octreotide on gastric mucosal massive hemorrhage in patients with portal hypertensive gastropathy].
    Le Q; Zhang J; Xu Q; Gao H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):68. PubMed ID: 11856512
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of octreotide for the treatment of severe gastrointestinal bleeding in children.
    Siafakas C; Fox VL; Nurko S
    J Pediatr Gastroenterol Nutr; 1998 Mar; 26(3):356-9. PubMed ID: 9523876
    [No Abstract]   [Full Text] [Related]  

  • 12. Octreotide long-active release in the treatment of gastrointestinal bleeding due to vascular malformations: Cost-effectiveness study.
    Klímová K; Padilla-Suárez C; Giménez-Manzorro Á; Pajares-Díaz JA; Clemente-Ricote G; Hernando-Alonso A
    Rev Esp Enferm Dig; 2015 Feb; 107(2):79-88. PubMed ID: 25659389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: octreotide as an adjunct to embolisation in the management of recurrent bleeding upper gastrointestinal metastases from primary renal cell cancer.
    Lamb GW; Moss J; Edwards R; Aitchison M
    Int Urol Nephrol; 2005; 37(4):691-3. PubMed ID: 16362580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Octreotide in the treatment of acute gastrointestinal hemorrhage caused by ruptured esophageal varices].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Oct; 82(10):947-50. PubMed ID: 15686191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effect of somatostatin analog octreotide on esophaged-gastric varices bleeding].
    Zhang AG; Wang JB; Zhao P; Jiao J; Wang G
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):152. PubMed ID: 12681061
    [No Abstract]   [Full Text] [Related]  

  • 16. Octreotide for control of bleeding peristomal varices in palliative care.
    Selby D; Jackson LD
    J Pain Symptom Manage; 2015 Mar; 49(3):e2-4. PubMed ID: 25543109
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery.
    Gullichsen R
    Tech Coloproctol; 2006 Dec; 10(4):346-9. PubMed ID: 17115310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.
    Loyaga-Rendon RY; Hashim T; Tallaj JA; Acharya D; Holman W; Kirklin J; Pamboukian SV
    ASAIO J; 2015; 61(1):107-9. PubMed ID: 25232774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
    Arts J; Caenepeel P; Bisschops R; Dewulf D; Holvoet L; Piessevaux H; Bourgeois S; Sifrim D; Janssens J; Tack J
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):432-7. PubMed ID: 19264574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhage.
    Alaniz C; Mohammad RA; Welage LS
    Pharmacotherapy; 2009 Mar; 29(3):248-54. PubMed ID: 19249944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.